ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements08/29/2024 [ad_1] ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements [ad_2] Source: Seekingalpha
